Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial-Reference-Cited by-同舟云学术

Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial

Published:2022-09 Issue:10357 Volume:400 Page:1008-1019
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kim Sungjune,Wuthrick Evan,Blakaj Dukagjin,Eroglu Zeynep,Verschraegen Claire,Thapa Ram,Mills Matthew,Dibs Khaled,Liveringhouse Casey,Russell Jeffery,Caudell Jimmy J,Tarhini Ahmad,Markowitz Joseph,Kendra Kari,Wu Richard,Chen Dung-Tsa,Berglund Anders,Michael Lauren,Aoki Mia,Wang Min-Hsuan,Hamaidi Imene,Cheng Pingyan,de la Iglesia Janis,Slebos Robbert J,Chung Christine H,Knepper Todd C,Moran-Segura Carlos M,Nguyen Jonathan V,Perez Bradford A,Rose Trevor,Harrison Louis,Messina Jane L,Sondak Vernon K,Tsai Kenneth Y,Khushalani Nikhil I,Brohl Andrew S

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities;Harms;Nat Rev Clin Oncol,2018

2. Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs;Schadendorf;Eur J Cancer,2017

3. The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy;Knepper;Clin Cancer Res,2019

4. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial;Kaufman;Lancet Oncol,2016

5. First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study;D'Angelo;J Immunother Cancer,2021

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profound ctDNA and radiological responses after 2 cycles of avelumab in a metastatic Merkel cell carcinoma of the head and neck;Oral Oncology;2024-10

2. Merkel Cell Carcinoma;Hematology/Oncology Clinics of North America;2024-10

3. Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma;Journal for ImmunoTherapy of Cancer;2024-09

4. Locoregional therapies combined with immune checkpoint inhibitors for liver metastases;Cancer Cell International;2024-08-31

5. The Role of the Large T Antigen in the Molecular Pathogenesis of Merkel Cell Carcinoma;Genes;2024-08-27